Controversially, while PRL overexpression in cell culture enhances tumor growth, PRLR knockdown or antagonism can lead to more aggressive but less differentiated tumors, highlighting the context-dependent nature of PRL's role in breast cancer. The gene discussed is PRL; the disease is breast carcinoma.